Clinical Trials · NCT00003394

Combination Chemotherapy in Treating Patients With Advanced Prostate Cancer

CompletedPhase 1/Phase 2Gonadorelin (Approved)
Phase
Phase 1/Phase 2
Recruitment status
Completed
Sponsor
Memorial Sloan Kettering Cancer Center
Enrollment
18
Start date
Apr 1998
Locations
1 site, United States
Primary endpoint
Study in Prostate Cancer
View Gonadorelin compound reference